Striatal astrocytes act as a reservoir for L-DOPA.

L-DOPA is therapeutically efficacious in patients with Parkinson's disease (PD), although dopamine (DA) neurons are severely degenerated. Since cortical astrocytes express neutral amino acid transporter (LAT) and DA transporter (DAT), the uptake and metabolism of L-DOPA and DA in striatal astro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Masato Asanuma, Ikuko Miyazaki, Shinki Murakami, Francisco J Diaz-Corrales, Norio Ogawa
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d3d1a899d08d4c9a853ca5954dbae6ca
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d3d1a899d08d4c9a853ca5954dbae6ca
record_format dspace
spelling oai:doaj.org-article:d3d1a899d08d4c9a853ca5954dbae6ca2021-11-25T06:01:53ZStriatal astrocytes act as a reservoir for L-DOPA.1932-620310.1371/journal.pone.0106362https://doaj.org/article/d3d1a899d08d4c9a853ca5954dbae6ca2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25188235/?tool=EBIhttps://doaj.org/toc/1932-6203L-DOPA is therapeutically efficacious in patients with Parkinson's disease (PD), although dopamine (DA) neurons are severely degenerated. Since cortical astrocytes express neutral amino acid transporter (LAT) and DA transporter (DAT), the uptake and metabolism of L-DOPA and DA in striatal astrocytes may influence their availability in the dopaminergic system of PD. To assess possible L-DOPA- and DA-uptake and metabolic properties of striatal astrocytes, we examined the expression of L-DOPA, DA and DAT in striatal astrocytes of hemi-parkinsonian model rats after repeated L-DOPA administration, and measured the contents of L-DOPA, DA and their metabolite in primary cultured striatal astrocytes after L-DOPA/DA treatment. Repeated injections of L-DOPA induced apparent L-DOPA- and DA-immunoreactivities and marked expression of DAT in reactive astrocytes on the lesioned side of the striatum in hemi-parkinsonian rats. Exposure to DA for 4h significantly increased the levels of DA and its metabolite DOPAC in cultured striatal astrocytes. L-DOPA was also markedly increased in cultured striatal astrocytes after 4-h L-DOPA exposure, but DA was not detected 4 or 8h after L-DOPA treatment, despite the expression of aromatic amino acid decarboxylase in astrocytes. Furthermore, the intracellular level of L-DOPA in cultured striatal astrocytes decreased rapidly after removal of extracellular L-DOPA. The results suggest that DA uptaken into striatal astrocytes is rapidly metabolized and that striatal astrocytes act as a reservoir of L-DOPA that govern the uptake or release of L-DOPA depending on extracellular L-DOPA concentration, but are less capable of converting L-DOPA to DA.Masato AsanumaIkuko MiyazakiShinki MurakamiFrancisco J Diaz-CorralesNorio OgawaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 9, p e106362 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Masato Asanuma
Ikuko Miyazaki
Shinki Murakami
Francisco J Diaz-Corrales
Norio Ogawa
Striatal astrocytes act as a reservoir for L-DOPA.
description L-DOPA is therapeutically efficacious in patients with Parkinson's disease (PD), although dopamine (DA) neurons are severely degenerated. Since cortical astrocytes express neutral amino acid transporter (LAT) and DA transporter (DAT), the uptake and metabolism of L-DOPA and DA in striatal astrocytes may influence their availability in the dopaminergic system of PD. To assess possible L-DOPA- and DA-uptake and metabolic properties of striatal astrocytes, we examined the expression of L-DOPA, DA and DAT in striatal astrocytes of hemi-parkinsonian model rats after repeated L-DOPA administration, and measured the contents of L-DOPA, DA and their metabolite in primary cultured striatal astrocytes after L-DOPA/DA treatment. Repeated injections of L-DOPA induced apparent L-DOPA- and DA-immunoreactivities and marked expression of DAT in reactive astrocytes on the lesioned side of the striatum in hemi-parkinsonian rats. Exposure to DA for 4h significantly increased the levels of DA and its metabolite DOPAC in cultured striatal astrocytes. L-DOPA was also markedly increased in cultured striatal astrocytes after 4-h L-DOPA exposure, but DA was not detected 4 or 8h after L-DOPA treatment, despite the expression of aromatic amino acid decarboxylase in astrocytes. Furthermore, the intracellular level of L-DOPA in cultured striatal astrocytes decreased rapidly after removal of extracellular L-DOPA. The results suggest that DA uptaken into striatal astrocytes is rapidly metabolized and that striatal astrocytes act as a reservoir of L-DOPA that govern the uptake or release of L-DOPA depending on extracellular L-DOPA concentration, but are less capable of converting L-DOPA to DA.
format article
author Masato Asanuma
Ikuko Miyazaki
Shinki Murakami
Francisco J Diaz-Corrales
Norio Ogawa
author_facet Masato Asanuma
Ikuko Miyazaki
Shinki Murakami
Francisco J Diaz-Corrales
Norio Ogawa
author_sort Masato Asanuma
title Striatal astrocytes act as a reservoir for L-DOPA.
title_short Striatal astrocytes act as a reservoir for L-DOPA.
title_full Striatal astrocytes act as a reservoir for L-DOPA.
title_fullStr Striatal astrocytes act as a reservoir for L-DOPA.
title_full_unstemmed Striatal astrocytes act as a reservoir for L-DOPA.
title_sort striatal astrocytes act as a reservoir for l-dopa.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/d3d1a899d08d4c9a853ca5954dbae6ca
work_keys_str_mv AT masatoasanuma striatalastrocytesactasareservoirforldopa
AT ikukomiyazaki striatalastrocytesactasareservoirforldopa
AT shinkimurakami striatalastrocytesactasareservoirforldopa
AT franciscojdiazcorrales striatalastrocytesactasareservoirforldopa
AT norioogawa striatalastrocytesactasareservoirforldopa
_version_ 1718414308271980544